Orangevale, CA based Biomagnetics Diagnostics Corporation has announced a licensing agreement with Los Alamos National Security LLC, in which Biomagnetics will receive the Los Alamos developed Integrated Optical Biosensor (IOBS). Unlike traditional diagnostic biosensors, the IOBS tests samples optically rather than chemically, and can provide results in 15 minutes. In addition to reducing the time required to provide test results, the IOBS does not require samples to be sent to a lab, thereby eliminating the chance of sample contamination during transport.
From the press release:
While Biomagnetics Diagnostics will be targeting tuberculosis and cholera detection in its first release, which is due for release later this year, and malaria diagnosis, which is slated for release toward the end of the year, the Company will not be limiting its product releases to only these diseases. With the flexibility of the underlying technology Biomagnetics will be able to adapt the IOBS to detect almost any pathogen in human or animal blood or other body fluids.
And here’s a technology overview:
Press release: Biomagnetics Presents First Handheld Optical Biosensor for Malaria, TB and HIV/AIDS Diagnostics in New Video Series…
IOBS technology overview (PDF)…